Sterling Capital Management LLC Replimune Group, Inc. Transaction History
Sterling Capital Management LLC
- $7.74 Trillion
- Q3 2024
A detailed history of Sterling Capital Management LLC transactions in Replimune Group, Inc. stock. As of the latest transaction made, Sterling Capital Management LLC holds 454 shares of REPL stock, worth $5,307. This represents 0.0% of its overall portfolio holdings.
Number of Shares
454Holding current value
$5,307% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding REPL
# of Institutions
158Shares Held
68.9MCall Options Held
26.7KPut Options Held
28.6K-
Baker Bros. Advisors LP New York, NY11MShares$129 Million1.3% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD9.88MShares$115 Million0.01% of portfolio
-
Fcpm Iii Services B.V. Naarden, P74.87MShares$56.9 Million9.16% of portfolio
-
Redmile Group, LLC San Francisco, CA4.78MShares$55.9 Million3.43% of portfolio
-
Black Rock Inc. New York, NY4.71MShares$55.1 Million0.0% of portfolio
About Replimune Group, Inc.
- Ticker REPL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,306,700
- Market Cap $576M
- Description
- Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...